An observational study in Frailty, Muscle Weakness and Volatile Organic Compounds, sponsored by University of Rostock. Recruiting at 1 site in Germany. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2023-12-18.
Sponsored by University of Rostock · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Frailty with a site in Germany — 7 open to participants now, 7 under way, none of them phase 3. Frailty · Germany.
Among the 33 studies in Frailty with a site in Germany, this one is the 17th largest by planned enrollment of the 20 observational ones that give a count, is one of 3 that started in 2023, is one of 20 observational ones, and was the 27th registered.
1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.
Browse Frailty studies →7 of the 33 studies in Frailty with a site in Germany are open now. Recruiting first, the newest first:
University Hospital, Ghent · Sites in Germany, Austria, Belgium and 5 more countries
Ages 18+
Universitätsklinikum Hamburg-Eppendorf · Sites in Germany
Ages 70+
Robert Bosch Medical Center · Sites in Germany
Ages 18+
Universitätsmedizin Mannheim · Sites in Germany
Ages 18+
University of Ulm · Sites in Germany
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 3 started in 2023.
This study's planned enrollment of 66 is below the median of 225 across 495 observational studies indexed under Frailty.
Median enrollment 164 across the 13 interventional studies, 203 across the 20 observational. Of the 19 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 33 have an industry lead sponsor. The 10 most frequent:
University of Rostock is the lead sponsor of 46 studies on the registry; 3 are open to participants now.
University of Rostock has 1 study filed under Frailty — fewer than ten, so there is no comparison to draw.
3 of the studies in Frailty with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07464106Robert Bosch Medical CenterEvaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults. | 2026-12 |
| NCT07026773University Hospital, GhentValidity of ICU Clinician's Appraisal of Proportionality in CPR | 2026-12-30 |
| NCT06889545Universitätsklinikum Hamburg-EppendorfComparison of Preoperative Frailty Assessment Tools | 2027-11-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 33 studies in Frailty with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The perioperative preservation of functionality and quality of life plays an increasingly important role in older physically limited and frail patients undergoing cardiac surgery. Hereby, impairments of the skeletal muscle system integrity often contributes to a reduced physical performance. Early identification of these high-risk patients could help to initiate appropriate preventive and therapeutic measures. Volatile organic compounds (VOC) represent a non-invasive and real-time measurable approach for recording physiological and pathophysiological processes. Isoprene (2-methyl-1,3-butadiene) is one of the most abundantly exhaled VOCs and has recently been shown to originate from skeletal muscle metabolism. However, the prognostic value of isoprene as a volatile biomarker for skeletal muscle integrity, physical performance and functional outcome in patients undergoing cardiac surgery has not been evaluated before.
This is a single center prospective observational study evaluating exhaled isoprene as a perioperative volatile biomarker of skeletal muscle integrity, physical performance and functional outcome in cardiosurgical patients. All study participants will be assessed by comprehensive clinical examinations, laboratory testing, breath analysis and skeletal muscle ultrasound before, during as well as five and thirty days after surgery. Clinical assessments will be performed using established clinical scores and scales (e.g. the Short Physical Performance Battery and the Fried Frailty Index). Laboratory testing comprises a broad panel of blood-based biomarkers of skeletal muscle integrity and metabolism.
The investigators hypothesize that:
Patients undergoing elective cardiac surgery
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients undergoing elective cardiac surgery
Diagnostic Test: Physical performance testing · Diagnostic Test: Breath sampling and VOC analysis · Diagnostic Test: Muscle ultrasound · Diagnostic Test: Blood-based biomarker analysis
Assessment of physical performance using established clinical tests and scoring systems
Sampling of exhaled breath and using Proton-transfer-reaction time-of-flight mass spectrometry (PTR-TOF) for VOC quantification.
Quantitative and qualitative assessment of different limb skeletal muscles using non-invasive ultrasound.
Blood sampling and assessment of different blood-based biomarkers of muscle integrity using Enzyme-linked Immunosorbent Assay (ELISA) and Electrochemiluminescence Immunoassay (ECLIA)
Short Physical Performance Battery
Assessment of patient's physical performance using the Short Physical Performance Battery (SPPB, Score, scales 0-12), whereby a higher SPPB corresponds to a better physical performance.
Time frame: day 5 after surgery
Cumulated Ambulation Score
Assessment of functional patient outcome using the Cumulated Ambulation Score (CAS, Score, scales 0-6), whereby a higher CAS corresponds to a better functional outcome.
Time frame: days 5 and 30 after surgery
Morbidity
Assessment of the cumulative number of postoperative complications after surgery.
Time frame: day 30 after surgery
Isoprene concentration in patients with and without frailty
Comparison of exhaled isoprene levels (concentrations, part per billion volume - ppbV) measured by PTR-TOF between patients with and without physical frailty.
Time frame: day 5 after surgery
Medical Research Council Sum Score
Assessment of general muscle strength of study participants using the Medical Research Council Sum Score (MRCSS, Score, scales 0-60), whereby a higher MRCSS corresponds to a higher muscle strength.
Time frame: day 5 after surgery
Muscle thickness
Assessment of muscle thickness (mm) using muscle ultrasound in eight different limb skeletal muscles.
Time frame: day 5 after surgery
Concentrations of blood-based biomarkers
Assessment of blood-based biomarker concentrations (pmol/l) of skeletal muscle integrity and metabolism.
Time frame: day 5 after surgery
Started Nov 2023 (actual). Primary completion is estimated for Oct 2025, 22 months after the start.
Of 291 non-industry observational studies under Frailty, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 55. This study's planned 22 months is below that.
Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 12 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Rostock